Merger Notification - Announcement according to § 10 Cartel Act

EQT Fund Managment S.à.r.l.; Fund VIII Swe Bidco AB; Karo Pharma AB - BWB/Z-4174 | Bundeswettbewerbsbehörde

EQT Fund Managment S.à.r.l.; Fund VIII Swe Bidco AB; Karo Pharma AB



On 07.11.2018 the Austrian Federal Competition Authority was notified of the following merger:

Planned purchase process

EQT VIII, an investment fund managed by EQT Fund Management S.à.r.l. (Luxembourg / Luxembourg), intends, through its wholly owned subsidiary Fund VIII Swe Bidco AB (under name change to Karo Intressenter AB), to acquire at least 90% of the shares in and sole control over Karo Pharma AB and its subsidiaries (Stockholm / Sweden) in accordance with the public offer published on 29th October 2018. The planned concentration concerns over-the-counter and prescription pharmaceuticals.

Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren

Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 05.12.2018.

Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.

Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.

Non-prohibition of the merger

The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 06.12.2018 .

back to list